Topic 7 · Treatment options
Particulated Juvenile Cartilage Allograft (DeNovo)
25.2% complication rate across 241 patients. Consensus says it “potentially enhances” restoration — an adjunct, not a plan.
Systematic Review Evidence (241 patients, 2024)
→ DeNovo uses tiny cartilage pieces from young donors (under 13). Young cartilage has more "stem cell-like" properties. Mixed with fibrin glue and placed into the defect.
Key Findings
- AOFAS improved from 58.5 to 83.9 [46]
- Most common complication: allograft hypertrophy (13.2%) [46]
- Lesions >125mm² had significantly increased failure risk [46]
- Male sex was a risk factor; age, BMI, prior surgery were NOT [46]
2024-2025 Clinical Updates
Recent studies have provided more data on particulated juvenile cartilage [83]:
- 5-year follow-up shows continued concern about durability
- Tissue quality on MRI remains fibrocartilaginous rather than hyaline
- Newer scaffold-assisted techniques may improve outcomes
11-Year Case Report
Long-term case report with second-look arthroscopy showed graft survival at 11 years [47].
Product Availability Note (2024)
DeNovo NT (natural tissue) is manufactured by Zimmer Biomet. Availability may be limited in some regions, and cost remains significant (~$5,000-8,000 for the graft alone) [84].
Conclusion: High complication and failure rates call into question efficacy for large OLTs. Cannot be currently recommended for lesions >125mm² [46].
Added August 4, 2026 — minced cartilage is now routine in European knees, and that gap is the point
→ A close cousin of this procedure has quietly become standard practice in one joint while the evidence in the ankle has not moved at all.
A survey of all 4,915 members of the German arthroscopy society, published August 3, found that minced cartilage implantation “has emerged as one of the three most commonly used cartilage repair techniques in the knee joint,” with “defect sizes up to 4 cm²… the largest treated group” [350]. 927 surgeons responded, a 19% response rate.
Read this carefully, because it is easy to over-read. The survey is knee only, contains no ankle data, and reports no outcomes whatsoever — it measures what surgeons say they do, not whether it works. It also found the technique is “quite heterogeneous, with some practitioners using a shaver and others manually mincing with a scalpel,” which means “minced cartilage” does not describe one standardised operation even where it is popular.
Why it belongs on this page anyway: it sharpens the asymmetry this page already documents. Particulated and minced cartilage techniques have crossed into everyday knee practice in Europe, while the talar evidence still rests on small series with high failure rates above 125 mm². Popularity in the knee is not evidence for the talus, and if this approach is ever offered here, that distinction is the question to press.